Autonomix Medical Inc. Co... (AMIX)
NASDAQ: AMIX
· Real-Time Price · USD
1.05
-0.01 (-0.94%)
At close: Aug 20, 2025, 3:59 PM
1.04
-0.95%
After-hours: Aug 20, 2025, 06:08 PM EDT
Autonomix Medical Common Stock Income Statement
Financials in USD. Fiscal
year is
April - March.
Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
Revenue | n/a | 86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 3K | n/a | 47K | 45K | 43K | 46K | 35K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -3K | 43K | -47K | -45K | -43K | -46K | -35K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -3.42M | -3.25M | -2.75M | -2.84M | -2.75M | -2.42M | -2.92M | -1.26M | -871K | -657K | -544K | -394K | -394K |
Interest Income | 84K | 107K | 80K | 72K | 95K | 80K | 23K | 19K | 6K | n/a | n/a | n/a | n/a |
Pretax Income | -3.34M | -3.19M | -2.71M | -2.81M | -2.7M | -5.41M | -3.11M | -6.04M | -865K | -657K | -544K | -394K | -394K |
Net Income | -3.34M | -3.19M | -2.71M | -2.81M | -2.7M | -5.41M | -3.11M | -6.04M | -865K | -657K | -544K | -394K | -394K |
Selling & General & Admin | 1.83M | 1.7M | 1.7M | 1.66M | 1.8M | 1.57M | 2.24M | 675.87K | 503K | 338.25K | 345K | 325.11K | 325.11K |
Research & Development | 1.59M | 1.55M | 1.04M | 1.17M | 954K | 841K | 601K | 391.28K | 368K | 319.23K | 199K | 69.09K | 69.09K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.42M | 3.25M | 2.75M | 2.84M | 2.75M | 2.37M | 2.89M | 1.26M | 871K | 657.48K | 544K | 394.2K | 394.2K |
Interest Expense | n/a | 46K | 45K | 43K | 41K | 46K | 33K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 1.3M | n/a | -173K | 88.25K | n/a | n/a | n/a |
Cost & Expenses | 3.42M | 3.25M | 2.75M | 2.84M | 2.75M | 2.42M | 2.92M | 3.46M | 871K | 657.48K | 544K | 394.2K | 394.2K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.38M | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.11M | 1.77M | 1.85M | 1.14M | 18.9M | 18.85M | 18.79M | 13.33M | 18.85M | 18.79M | 21.12M | 12M | 599K |
Shares Outstanding (Diluted) | 3.11M | 1.77M | 1.85M | 1.14M | 18.9M | 18.85M | 18.79M | 13.33M | 18.85M | 18.79M | 21.12M | 12M | 599.95K |
EPS (Basic) | -1.07 | -1.81 | -1.46 | -2.47 | -0.14 | -0.29 | -0.17 | -5.72 | -0.05 | -0.04 | -0.03 | -0.03 | -0.66 |
EPS (Diluted) | -1.07 | -1.81 | -1.46 | -2.47 | -0.14 | -0.29 | -0.17 | -5.72 | -0.05 | -0.04 | -0.03 | -0.03 | -0.66 |
EBITDA | -3.33M | -3.1M | -2.62M | -2.72M | -2.62M | -5.32M | -3.04M | -2.38M | -865K | n/a | -544K | n/a | n/a |
EBIT | -3.34M | -3.15M | -2.67M | -2.76M | -2.66M | -5.36M | -3.08M | -1.26M | -865K | -657K | -544K | n/a | -394K |
Depreciation & Amortization | 3K | 48K | 47K | 45K | 43K | 46K | 35K | 1.07M | 871K | 657K | 544K | 394.2K | 394.2K |